My Ultimate Sign-in System Made Me Invincible Chapter 493 Moral Vs Logic

Days bled into one another as time marched forward. It had already been over forty-eight hours since Nova Technologies debuted their Institutional Verification initiative, and during that timeframe, a handful of verified institutional accounts had successfully emerged.

Governmental bodies secured their verification badges first; proving legal standing for such established public entities was far more straightforward than navigating the labyrinthine corporate structures of multinational conglomerates.

Within two days, the United Nations, several national governments, and key regulatory authorities showcased the unmistakable verified institutional badge, signaling their authenticated status on LucidNet.

Nevertheless, a number of major corporations also achieved verification, including some heavy hitters. Miçrōṣōft. Tōyōtā. Dēutṣchē Bank. Sāmsung.

Every verification mark signified countless hours of auditing legal paperwork, dissecting internal structures, and confirming authorized personnel—all completed with the staggering efficiency synonymous with Nova Technologies' operational systems.

These verified accounts wasted no time in establishing an official foothold. Government agencies began disseminating public health updates, corporations launched strategic brand channels, and academic centers rolled out specialized content hubs.

Yet, while the buzz surrounding Institutional Verification lingered in certain circles, it paled in comparison to the firestorm ignited by the reveal of Medical Nanites.

Absolutely nothing could eclipse it.

The mere mention of this technology triggered massive, heated debates. A solitary post questioning, "what if Medical Nanites are actually real," could draw thousands of replies in minutes, spiraling into epic arguments covering healthcare economics, the fragility of human life, and whether Nova Technologies held moral duties beyond its private corporate scope.

An entire faction of the public became determined to frame the rollout of these nanites as a profound moral crisis. They argued that because Nova Technologies possessed the power to eradicate human suffering on such a grand scale, they were obligated to distribute the treatment as quickly and broadly as possible, ignoring all financial motives.

While the arguments were predictable in their trajectory, the raw intensity behind them was undeniable.

One user authored a thread that hit viral status within hours: "Nova Technologies has unlocked the power to cure cancer, regenerate limbs, heal spinal trauma, and reverse genetic diseases. They have the capability to end misery for millions. Yet, they choose to gatekeep this behind a $99 to $4,999 monthly cost, while forcing users to win a literal lottery just to access a Lucid device. This is morally bankrupt. This is prioritizing profit over existence. This is letting people die when you hold the cure in your hands."

The thread spanned eighteen posts, layering arguments about ethical duty, corporate accountability, and the fundamental right to medical care. It amassed 847,000 likes, 234,000 shares, and over 50,000 replies within the first six hours.

Other users framed the situation in even sterner moral terms: "We are watching a corporation play god, selecting who lives and who dies via subscriptions and random draws. This isn't healthcare. It is eugenics with a thin veil of convenience. Nova Technologies has a basic moral obligation to provide this to everyone in need at an affordable price, rather than manufacturing scarcity to drive demand."

These protestors wielded historical analogies with the sharpness of academic papers, citing the COVID-19 vaccine rollout, insulin price gouging, and Jonas Salk's famous declaration that one cannot patent the sun. They compared the situation to organ transplant queues, asserting that artificial scarcity in medicine inevitably costs lives.

The emotional toll of these pleas was hard to ignore. They represented genuine agony over human suffering and profound fear of a future where life-saving tech is kept out of reach for millions.

However, the counter-movement was equally ferocious, refusing to cede the moral or intellectual high ground.

Another user published a rebuttal thread that garnered just as much attention: "Nova Technologies has zero obligation to play the savior. They are not a government. They did not invent our broken healthcare industry. They aren't the ones charging $3,000 for an ambulance or keeping insulin at criminal prices. Those are systemic failures of our current government and infrastructure. Nova Technologies is actually providing a solution that is dirt cheap compared to the bloated costs of our current, inferior status quo."

The post continued with brutal economic pragmatism: "People die every day, and they will continue to die tomorrow regardless of Nova Technologies' actions. These deaths are not the fault of the company. Demanding they fix the world’s woes just because they possess the means is a logical fallacy fueled by emotional blackmail."

Another supporter offered a different perspective: "Those complaining about the cost completely ignore that the Sovereign tier—at $4,999 a month—provides capabilities that would cost tens of millions in today’s system. Regrowing limbs? That is an experimental procedure often costing upward of $200,000. Stage 4 cancer treatment? That can exceed $400,000 in the US alone. This is not exploitation; it is a total bargain."

A different user provided sharp, comparative data: "People are losing their minds over a monthly subscription while ignoring that a single hospital admission costs $50,000. The math is not the villain here. The villain is a healthcare baseline that is so catastrophically mangled that revolutionary, life-saving tech appears expensive by comparison."

The debates grew increasingly granular, with supporters firing back with data to dismantle the critics. Comparisons of nanite subscription costs versus existing pharmaceutical spending flooded the feeds, highlighting that the subscription was often cheaper than standard health insurance plans for objectively worse care.

One user delivered a particularly stinging comparison: "You call Nova Technologies evil for charging $99 a month for Essential access? Meanwhile, insulin costing $10 to make sells for $300, and auto-injectors cost $600 despite being pennies to produce. We live in a world where pharma companies gouge people for thousands of percent in profit, and nobody whispers a word. Nova Technologies makes those medications obsolete, and suddenly everyone is a philosopher. You all need to shut up."

Yet, the most persuasive argument came from a user who shifted the entire narrative focus: "Everyone screaming for 'free' nanites ignores that Nova Technologies is already offering something millions of times cheaper than the current system. The real question is: why have we let governments and big pharma charge obscene amounts for inferior care for decades while nobody dared to challenge them until a better option finally appeared?"

The thread concluded: "You want to know what would make nanites accessible to everyone? If our governments funded health instead of wars. Nova Technologies isn't the problem. They are just the mirror, forcing everyone to finally acknowledge how broken the rest of society truly is."

The arguments raged unabated, neither side relenting. The moralists maintained that ability equated to accountability, insisting that Nova Technologies was ethically bound to provide aid regardless of economic consequences.

The pragmatists countered that a private firm held no such responsibility, noting that Nova Technologies was providing unprecedented value and that demanding them to solve decades-old systemic government failures was entirely illogical.

Those who remained impartial watched the chaos with the grim fascination of a slow-motion train wreck.

They understood that the moral group was trying to guilt Nova Technologies into shifting its rollout, but they also recognized the futility of such tactics.

Nova Technologies had long proven that it didn't pivot based on public outcry, government demands, or moral pleas. They operated on their own schedule, by their own rules, and with complete indifference to outside pressure. Trying to guilt-trip them was like shouting into a hurricane—pointless and exhausting.

The firm's absolute silence throughout the ordeal only added fuel to the fire. People hungered for answers, for validation, for a seat at the table. Their failure to engage after being tagged in endless threads only deepened the public’s rage.

That pent-up frustration had to vent somewhere. When they couldn't wound the company, the critics pivoted to attacking the company’s supporters, branding them as corporate lapdogs blind to human tragedy.

The conflict escalated into full-blown flame wars. Comment sections turned into trenches. Exchanges turned vile. One side branded the other as heartless profiteers, while the other called their critics entitled and economically illiterate.

One user barked: "If you defend Nova Technologies' artificial scarcity while people die, you are complicit. End of story."

Another fired back: "If you think demanding private entities fix government-created crises makes you morally pure, you are delusional. End of story."

Toxicity hit new heights. The conversation shifted from Medical Nanites to a proxy war over capitalism, the ethics of healthcare, and the role of innovation.

Through it all, Nova Technologies stayed stone-cold silent. No press releases. No clarifications. No engagement with the tempest raging on their own servers.

This silence was maddening for those seeking a response, though it was perfectly predictable for those who understood the company's nature.

And then, right as the discourse peaked, as both sides were fully locked in ideological warfare, as the entire internet was debating the ethics of progress—

Nova Technologies dropped their announcement.

The notification pulsed across LucidNet simultaneously for everyone. The timing was almost certainly calculated, hitting at the exact moment public focus was at its zenith.

The bickering ceased instantaneously as millions frantically opened the alert, desperate to see how the company would address the storm that had consumed the world for days.

What they found was quintessentially Nova Technologies—methodical, precise, and entirely indifferent to the moral panic that had preceded it.